BNF_13

Created on 31 May 2016
This resource  supports the review of prescribing of sunscreens to ensure that any prescribing is for products on the ACBS list and that it meets ACBS criteria. A patient information leaflet advising ...
This bulletin covers the use of shampoos and scalp preparations for scalp psoriasis and seborrhoeic dermatitis. Implementation tools include an audit, patient letter and educational slideset.  Shampoos ...
The emollients bulletin reviews the cost effective choices and appropriate prescribing of emollients. It gives advice on first line choices for different types of emollient. Patient information is also ...
This bulletin reviews the place in therapy for Dovobet and discusses the concerns about long term continuous use. It provides guidance and support for those wishing to review prescribing and ensure ...
As part of the PrescQIPP Priorities Advisory Committee work delivered on behalf of the East of England, we have now released a policy statement (full review and summary) around Brimonidine tartrate ...
We're pleased to finally launch bulletin 49 Cost effective emollients with no, or low paraffin content. This bulletin (solely guidance without data pack or briefing) highlights emollient products ...
We're pleased to release the 6 month update to the Data pack that accompanies Bulletin 57. Eflornithine cream.  Eflornithine For more information on our data packs visit Data ...
This bulletin is no. 12 on the PrescQIPP DROP-List and focuses on topical antifungal nail treatment, i.e. amorolfine 5% nail lacquer (Loceryl®, Curanail®, Omicur®), tioconazole 28% cutaneous ...
This bulletin focuses on eflornithine cream which is a low priority treatment considered as a cosmetic treatment for hirsutism in women. It provides the rationale for self-funded hair removal methods ...